Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome profiling (RNA-seq) of chemotherapy treated CRC organoids

ABSTRACT: Transcriptome profiling (RNA-seq) of chemotherapy treated CRC organoids

PROVIDER: PRJNA857885 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR20083835.fastq.gz	Fastqsanger.gz
	SRR20083836.fastq.gz	Fastqsanger.gz
	SRR20083837.fastq.gz	Fastqsanger.gz
	SRR20083838.fastq.gz	Fastqsanger.gz
	SRR20083839.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Transcriptome profiling (RNA-seq) of chemotherapy treated CRC organoids

Project description:The main goal of this study was to analyze transcriptional differences between AKP CRC organoids treated or not with chemotherapy (FOLFIRI) by RNA-seq.

2022-09-16 | GSE207974 | GEO

Expression data from CRC patient-derived organoids

Project description:Expression data from CRC patient-derived organoids

| PRJNA526815 | ENA

RNA sequencing of CRC tumor organoids engineered with key driver mutations

Project description:We profiled CRC organoids engineered with different combinations of driver mutations. All organoids were derived from one mouse and then mutations were sequentially introduced by CRISPR Cas9

2022-09-16 | GSE207668 | GEO

Expression data from CRC patient-derived organoids

Project description:Colorectal cancer (CRC) is a commonly occurring cancer worldwide. Metastasis and recurrence are the major causes of cancer-related death. CRC progression is a multistep process, and extensive efforts have been made to identify the genomic and transcriptomic alterations that occur during this process. However, whether primary tumors and metastatic lesions possess distinct biological features remains unclear. We established 74 patient-derived organoids (PDOs) from primary tumors and patient-matched metastatic and recurrent lesions.

2021-04-01 | GSE128213 | GEO

CRC

Project description:Arabidopsis thaliana CRC, Transcription factor CRC [Source:UniProtKB/TrEMBL;Acc:Q1PFF1], is differentially expressed in 11 experiment(s);

| AT1G69180 | ExpressionAtlas

CRC

Project description:Arabidopsis thaliana CRC, Transcription factor CRC [Source:UniProtKB/TrEMBL;Acc:Q1PFF1], is expressed in 8 baseline experiment(s);

| AT1G69180 | ExpressionAtlas

Characterization of the Chemotherapy-treated PyMT Matrisome

Project description:Cytotoxic chemotherapy is used to treat many thousands of patients across many cancer types annually. Recent studies have demonstrated that chemotherapy causes systemic response that can be exploited to promote cancer cell survival and dissemination, termed “chemotherapy-induced metastasis. However, there have been no studies investigating how chemotherapy alters the extracellular matrix of breast tumors, or if those changes might help to support metastatic dissemination. Here, we report the first characterization of the chemotherapy-treated breast cancer matrisome using the MMTV-PyMT transgenic mouse model of breast cancer. We identify distinct changes induced by different cytotoxic chemotherapies. In particular, we identify collagen IV as significantly associated with taxane-based chemotherapy treatment. Biological validation confirmed collagen IV as chemotherapy-associated and identified collagen IV-driven Src and FAK signaling as important mediators of invasion in the post-chemotherapy tumor microenvironment.

2022-03-14 | PXD032002 | Pride

CRC

Project description:Arabidopsis thaliana CRC, 12S seed storage protein CRC [Source:UniProtKB/Swiss-Prot;Acc:Q96318], is expressed in 8 baseline experiment(s);

| AT4G28520 | ExpressionAtlas

CRC

Project description:Arabidopsis thaliana CRC, 12S seed storage protein CRC [Source:UniProtKB/Swiss-Prot;Acc:Q96318], is differentially expressed in 37 experiment(s);

| AT4G28520 | ExpressionAtlas

Characterization of Chemotherapy-treated PyMT Liver Matrisome

Project description:Metastasis accounts for 90% of cancer-related deaths, yet the mechanisms by which cancer cells colonize secondary organs remain poorly understood. For breast cancer patients, metastasis to the liver is associated with poor prognosis and a median survival of 6 months. Standard of care is chemotherapy, but recurrence occurs in 30% of patients. Systemic chemotherapy has been shown to induce hepatotoxicity and fibrosis, but how chemotherapy impacts the composition of the liver extracellular matrix (ECM) remains unknown. Individual ECM proteins drive tumor cell proliferation and invasion, features that are essential for metastatic outgrowth in the liver. Here, we characterize the liver ECM of tumor-bearing mice treated with and without chemotherapy using the MMTV-PyMT transgenic model of breast cancer. We identify distinct drug-specific changes induced by commonly used cytotoxic chemotherapies. We identify Collagen V as an ECM protein that is more abundant in livers isolated from paclitaxel-treated mice and identify mechanisms of Collagen V driven invasion via ECM organization and signaling through α1β1 integrins.

2022-10-05 | PXD036736 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data